IBIO, INC. Form SC TO-C: Written communication relating to a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2018-12-17: Form SC TO-C; Description SC TO-C; Document tv509290_sctoc.htm.
- 2018-12-17: Form SC TO-C; Description SC TO-C; Document tv509288_sctoc.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2018-12-17 | SC TO-C | SC TO-C | tv509290_sctoc.htm | |
| 2018-12-17 | SC TO-C | SC TO-C | tv509288_sctoc.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |